Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_assertion type Assertion NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_head.
- NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_assertion description "[Therefore, targeting inflammation along with the newly identified targets, such as MMP10 and S100A15, represents promising therapeutic strategies to treat SCCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_provenance.
- NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_assertion evidence source_evidence_literature NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_provenance.
- NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_assertion SIO_000772 24029918 NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_provenance.
- NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_assertion wasDerivedFrom befree-20150227 NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_provenance.
- NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_assertion wasGeneratedBy ECO_0000203 NP565236.RA_vR3W89Sb-Wh0s5G5PSzm__VdZlxrzwdWZIp1VbJWP4130_provenance.